IRIS
BARRECA, Maria Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.949
EU - Europa 1.430
AS - Asia 486
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
SA - Sud America 2
Totale 3.878
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.927
IE - Irlanda 373
SE - Svezia 323
UA - Ucraina 280
CN - Cina 256
DE - Germania 155
VN - Vietnam 117
GB - Regno Unito 102
FI - Finlandia 78
SG - Singapore 75
IT - Italia 29
IN - India 27
RU - Federazione Russa 23
CA - Canada 21
CZ - Repubblica Ceca 18
BE - Belgio 14
FR - Francia 6
IR - Iran 6
PL - Polonia 6
AT - Austria 4
TN - Tunisia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BG - Bulgaria 3
CH - Svizzera 3
NL - Olanda 3
CL - Cile 2
EG - Egitto 2
NZ - Nuova Zelanda 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
DK - Danimarca 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IS - Islanda 1
JP - Giappone 1
KR - Corea 1
LT - Lituania 1
LV - Lettonia 1
PA - Panama 1
PH - Filippine 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 3.878
Salva come PNG Salva come JPEG
Città #
Jacksonville 487
Dublin 373
Chandler 364
Nyköping 224
Ashburn 128
Dong Ket 115
Beijing 114
Princeton 75
Cambridge 73
Medford 71
Des Moines 58
Boardman 50
Singapore 47
Dearborn 41
Los Angeles 31
Lancaster 28
Ann Arbor 27
Woodbridge 27
Wilmington 19
Brno 18
Nanjing 18
Haikou 15
Jinan 15
Brussels 14
Ottawa 14
Hebei 12
Hyderabad 12
Shenyang 11
Taizhou 11
Washington 11
Saint Petersburg 10
Pune 9
San Mateo 9
Seattle 9
Munich 8
Zhengzhou 8
Hangzhou 7
Norwalk 7
Auburn Hills 6
Leawood 6
London 6
Tianjin 6
Warsaw 6
Ardabil 5
Riva 5
Taiyuan 5
Fuzhou 4
Monmouth Junction 4
Nanchang 4
Ningbo 4
Toronto 4
Tunis 4
West Jordan 4
Augusta 3
Brooklyn 3
Cormeilles-en-Parisis 3
Edinburgh 3
Frankfurt am Main 3
Lappeenranta 3
Mcallen 3
Milan 3
Montréal 3
New York 3
Sofia 3
Vienna 3
Amsterdam 2
Auckland 2
Bangalore 2
Cairo 2
Como 2
Dallas 2
Eden Prairie 2
Ferrara 2
Guangzhou 2
Helsinki 2
Houston 2
Kemerovo 2
Lanzhou 2
Manchester 2
Nanning 2
Novokuznetsk 2
Nuremberg 2
Pagani 2
Perugia 2
Albuquerque 1
Atlanta 1
Boston 1
Bratislava 1
Bucharest 1
Budapest 1
Cagliari 1
Catania 1
Changsha 1
Chicago 1
Clearwater 1
Copenhagen 1
Corleone 1
Cupertino 1
Dubai 1
Evanston 1
Totale 2.733
Salva come PNG Salva come JPEG
Nome #
1,3-diidro-benzimidazoloni analoghi: progettazione, sintesi e SAR di nuovi inibitori non-nucleosidici dell'RT 200
1,3-THIAZOLIDIN-4-ONES:POTENT AND HIGHLY SELECTIVE ANTI-HIV-1 AGENTS 153
5-Arylidene-2-imino-4-thiazolidinones: Design and synthesis of novel anti-inflammatory agents 71
Anti-HIV agents: design and discovery of new potent RT inhibitors 70
Structure-activity hypothesis in the design of new AMPA receptor antagonists. 67
Progettazione Sintesi e SAR di nuovi derivati tetraidroisochinolinici. 65
Binding modes of noncompetitive AMPA antagonists: a computational approach 65
Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs) 64
Analysis of the full-length integrase-DNA complex by a modified approach for DNA docking 64
Anticonvulsant activity of tetrahydroisoquinoline derivatives as potential new AMPA receptor antagonists 62
3-D QSAR MODELS AND DOCKING STUDIES OF REVERSIBLE INHIBITORS OF TYPE A AND B MONOAMINE OXIDASE 61
Computational studies of inhibitor resistance in HIV-1 integrase 61
Efficient 3D Database screening for novel HIV-1 IN inhibitors 60
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 59
Design, synthesis, structure-activity relationships, and molecular modeling studies of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV agents 59
Binding mode prediction of Strand Transfer HIV-1 Integrase Inhibitors using Tn5 transposase as a plausible surrogate model for HIV-1 Integrase 59
QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor 59
DISCOVERY OF 2,3-DIARYL-1,3-THIAZOLIDIN-4-ONES AS POTENT HIV-1 NNRTIS BY MOLECULAR MODELING STUDIES 58
HIV-1 Integrase Inhibitors: Pharmacophore Modeling and Rational Drug Design 56
Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti- HIV-1 agents 55
Homology Modelling of AMPA Receptors: Route to the Identification of Noncompetitive Antagonists Binding Site 55
Sviluppo del modello DNA-integrasi dell'HIV-1: studi di docking e di dinamica molecolare 55
Drug design and synthetic approach for the discovery of novel HIV-1 integrase inhibitors 54
Noncompetitive AMPA receptor antagonists: Synthetic approaches, molecular modeling and pharmacological profile 54
Progettazione razionale e "green" sintesi di nuovi inibitori dell'integrasi dell'HIV-1 53
Dynamic pharmacophore model development and testing 53
Design and synthesis of new HIV-1 NNRTIs 53
Synthesis and anticonvulsant properties of 1,2,3,4-tetrahydroisoquinolin-1-ones 53
Molecular modeling e disign di inibitori dell'integrasi dell'HIV-1 53
Search fo non-competitive AMPA antagonists: Synthesis, pharmacological properties and computational studies 53
Antagonisti non-competitivi del recettore AMPA: progettazione, sintesi, SAR e studio del profilo farmacocinetico 53
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 53
Design and synthesis of 2,3-diaryl-1,3-thiazolidin-4one potent HIV-1 RT-inhibitors. 53
COMPUTATIONAL APPROACHES IN DISCOVERING NOVEL ANTI-AIDS AGENTS 52
Pharmacophore-based design of HIV-1 integrase inhibitors 51
New trends in the development of AMPA receptor antagonists 51
MD STUDIES OF THE WILD TYPE AND MUTANT HIV-1 INTEGRASE COMPLEXED WITH THE 5CITEP INHIBITOR: MECHANISM FOR INHIBITION AND DRUG RESISTANCE 51
Tetrahydroisoquinoline derivatives: a new class of non-competitive AMPA receptor antagonists with potential anticonvulsant activity 50
Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT 50
Synthesis of new potential HIV-1 integrase inhibitors 50
Design and Synthesis of NR2B Subtype-Selective Antagonist 49
Computational and synthetic approaches for the discovery of HIV-1 integrase inhibitors 48
DISCOVERY OF HIV-1 INTEGRASE INHIBITORS BY MOLECULAR MODELING STUDIES 47
Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists 47
Noncompetitive AMPA receptor antagonists and proposed pharmacophore model 44
Search for noncompetitive 2-amino-3(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid receptor (AMPAR) antagonists: Synthesis, pharmacological properties, and computational studies 43
Molecular dynamics studies of the HIV-1 integrase 43
Design e sintesi di nuovi antagonisti noncompetitivi del recettore AMPA 43
Tetrahydroisoquinoline a new class of noncompetitive AMPA receptor antagonists as potential anticonvulsant agents 42
Design e sintesi di nuovi inibitori dell'integrasi dell'HIV-1 42
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist 42
Molecular dynamics studies of the full-length integrase-DNA complex 41
Discovery of novel HIV-1 integrase inhibitors through computational strategies 41
Tetrahydroisoquinolin-1-ones as anticonvulsant agents 41
Discovery of a new class of AMPA receptor antagonists containing a tetrahydroisoquinoline skeleton, 41
Rational design and synthesis of novel NNRTI TBZ analogues 41
Molecular dynamics studies of the wild-type and double mutant HIV-1 integrase complexed with the 5CITEP inhibitor: Mechanism for inhibition and drug resistance 41
PROPOSED MECHANISM FOR THE HIV-1 IN INHIBITION AND DRUG RESISTANCE BY MOLECULAR DYNAMICS STUDIES 40
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 40
DYNAMIC PHARMACOPHORE MODEL DEVELOPMENT AND TESTING 39
NNRTI TBZ-ANALOGHI: PROGETTAZIONE RAZIONALE, SINTESI E SAR 38
Rational design, synthesis and SAR of HIV-1 integrase Inhibitors 37
Isoquinoline derivatives as noncompetitive AMPA receptor antagonists 36
Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors 36
Computational Strategies for Discovering novel HIV-1 RT Inhibitors 35
A comprehensive structural overview of p38α MAPK in complex with type I inhibitors 35
null 28
Progettazione di nuovi agenti anti-HIV e individuazione di nuovi lead compound 28
A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series 27
Human immunodeficiency virus integrase inhibitors efficiently suppress feline immunodeficiency virus replication in vitro and provide a rationale to redesign antiretroviral treatment for feline AIDS 27
null 27
null 27
null 25
null 25
null 24
Pharmacophore-Based Design of HIV-1 Integrase Strand-Transfer Inhibitors 24
Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside riverse transcriptase inhibitors 18
Docking studies on a new human immunodeficiency virus integrase-Mg-DNA complex: phenyl ring exploration and synthesis of 1H-benzylindole derivatives through fluorine substitutions 17
Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors 16
Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors 12
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 6
Totale 3.921
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020456 0 0 0 67 2 41 80 71 10 75 107 3
2020/2021597 74 0 105 15 7 68 1 69 1 79 48 130
2021/2022457 5 119 3 10 35 0 42 13 8 1 62 159
2022/20231.321 94 90 65 108 108 157 30 99 493 5 65 7
2023/2024339 26 53 17 46 34 68 8 26 1 29 8 23
2024/2025127 20 35 49 23 0 0 0 0 0 0 0 0
Totale 3.921